Addressing challenges in developing a core domain set in adherence interventions in rheumatology

A report from the OMERACT-Adherence Group

Ayano Kelly, Susan J. Bartlett, Maarten P. De Wit, Dorcas E. Beaton, Therese Dawson, Vicki Evans, Michael Gill, Geraldine Hassett, Lyn March, Marieke Scholte-Voshaar, Jasvinder A. Singh, Allison Tong, Peter Tugwell, Peter Wong, Kathleen Tymms

Research output: Contribution to journalArticle

Abstract

Objective: The OMERACT-Adherence meeting was convened to discuss the conceptual and methodological challenges in developing a core domain set (Adherence-CDS) for trials of interventions for medication adherence in rheumatology. Methods: Forty participants from nine countries participated. Results: Four ideas emerged: for adherence trials, the Adherence-CDS could include adherence and the condition-specific CDS; many factors affect adherence and are intervention targets, contextual factors, or outcome domains; adherence is a critical factor in drug trials; and standardized adherence measures are needed. Conclusion: Despite the challenges, the meeting clarified an approach to developing an Adherence-CDS that complements existing OMERACT work and methodology.

Original languageEnglish
Pages (from-to)1202-1206
Number of pages5
JournalJournal of Rheumatology
Volume46
Issue number9
DOIs
Publication statusPublished - Sep 2019

Fingerprint

Medication Adherence
Rheumatology
Pharmaceutical Preparations

Cite this

Kelly, Ayano ; Bartlett, Susan J. ; De Wit, Maarten P. ; Beaton, Dorcas E. ; Dawson, Therese ; Evans, Vicki ; Gill, Michael ; Hassett, Geraldine ; March, Lyn ; Scholte-Voshaar, Marieke ; Singh, Jasvinder A. ; Tong, Allison ; Tugwell, Peter ; Wong, Peter ; Tymms, Kathleen. / Addressing challenges in developing a core domain set in adherence interventions in rheumatology : A report from the OMERACT-Adherence Group. In: Journal of Rheumatology. 2019 ; Vol. 46, No. 9. pp. 1202-1206.
@article{1d00815cd6644be58bb54df8d129cd67,
title = "Addressing challenges in developing a core domain set in adherence interventions in rheumatology: A report from the OMERACT-Adherence Group",
abstract = "Objective: The OMERACT-Adherence meeting was convened to discuss the conceptual and methodological challenges in developing a core domain set (Adherence-CDS) for trials of interventions for medication adherence in rheumatology. Methods: Forty participants from nine countries participated. Results: Four ideas emerged: for adherence trials, the Adherence-CDS could include adherence and the condition-specific CDS; many factors affect adherence and are intervention targets, contextual factors, or outcome domains; adherence is a critical factor in drug trials; and standardized adherence measures are needed. Conclusion: Despite the challenges, the meeting clarified an approach to developing an Adherence-CDS that complements existing OMERACT work and methodology.",
keywords = "Omeract, Outcome assessment (healthcare), Rheumatic diseases, Treatment adherence and compliance",
author = "Ayano Kelly and Bartlett, {Susan J.} and {De Wit}, {Maarten P.} and Beaton, {Dorcas E.} and Therese Dawson and Vicki Evans and Michael Gill and Geraldine Hassett and Lyn March and Marieke Scholte-Voshaar and Singh, {Jasvinder A.} and Allison Tong and Peter Tugwell and Peter Wong and Kathleen Tymms",
year = "2019",
month = "9",
doi = "10.3899/jrheum.181078",
language = "English",
volume = "46",
pages = "1202--1206",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "9",

}

Kelly, A, Bartlett, SJ, De Wit, MP, Beaton, DE, Dawson, T, Evans, V, Gill, M, Hassett, G, March, L, Scholte-Voshaar, M, Singh, JA, Tong, A, Tugwell, P, Wong, P & Tymms, K 2019, 'Addressing challenges in developing a core domain set in adherence interventions in rheumatology: A report from the OMERACT-Adherence Group', Journal of Rheumatology, vol. 46, no. 9, pp. 1202-1206. https://doi.org/10.3899/jrheum.181078

Addressing challenges in developing a core domain set in adherence interventions in rheumatology : A report from the OMERACT-Adherence Group. / Kelly, Ayano; Bartlett, Susan J.; De Wit, Maarten P.; Beaton, Dorcas E.; Dawson, Therese; Evans, Vicki; Gill, Michael; Hassett, Geraldine; March, Lyn; Scholte-Voshaar, Marieke; Singh, Jasvinder A.; Tong, Allison; Tugwell, Peter; Wong, Peter; Tymms, Kathleen.

In: Journal of Rheumatology, Vol. 46, No. 9, 09.2019, p. 1202-1206.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Addressing challenges in developing a core domain set in adherence interventions in rheumatology

T2 - A report from the OMERACT-Adherence Group

AU - Kelly, Ayano

AU - Bartlett, Susan J.

AU - De Wit, Maarten P.

AU - Beaton, Dorcas E.

AU - Dawson, Therese

AU - Evans, Vicki

AU - Gill, Michael

AU - Hassett, Geraldine

AU - March, Lyn

AU - Scholte-Voshaar, Marieke

AU - Singh, Jasvinder A.

AU - Tong, Allison

AU - Tugwell, Peter

AU - Wong, Peter

AU - Tymms, Kathleen

PY - 2019/9

Y1 - 2019/9

N2 - Objective: The OMERACT-Adherence meeting was convened to discuss the conceptual and methodological challenges in developing a core domain set (Adherence-CDS) for trials of interventions for medication adherence in rheumatology. Methods: Forty participants from nine countries participated. Results: Four ideas emerged: for adherence trials, the Adherence-CDS could include adherence and the condition-specific CDS; many factors affect adherence and are intervention targets, contextual factors, or outcome domains; adherence is a critical factor in drug trials; and standardized adherence measures are needed. Conclusion: Despite the challenges, the meeting clarified an approach to developing an Adherence-CDS that complements existing OMERACT work and methodology.

AB - Objective: The OMERACT-Adherence meeting was convened to discuss the conceptual and methodological challenges in developing a core domain set (Adherence-CDS) for trials of interventions for medication adherence in rheumatology. Methods: Forty participants from nine countries participated. Results: Four ideas emerged: for adherence trials, the Adherence-CDS could include adherence and the condition-specific CDS; many factors affect adherence and are intervention targets, contextual factors, or outcome domains; adherence is a critical factor in drug trials; and standardized adherence measures are needed. Conclusion: Despite the challenges, the meeting clarified an approach to developing an Adherence-CDS that complements existing OMERACT work and methodology.

KW - Omeract

KW - Outcome assessment (healthcare)

KW - Rheumatic diseases

KW - Treatment adherence and compliance

UR - http://www.scopus.com/inward/record.url?scp=85071756771&partnerID=8YFLogxK

U2 - 10.3899/jrheum.181078

DO - 10.3899/jrheum.181078

M3 - Article

VL - 46

SP - 1202

EP - 1206

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 9

ER -